This factsheet provides an overview of medication abortion, with a focus on federal and state regulations pertaining to its provision and coverage, and the role of the drug in self-managed abortions.
Featured Abortion Resources
Related Abortion Resources
- Reading the Post-Roe Tea Leaves in States Without Abortion Bans or Protections
- KFF Health Tracking Poll: Views on and Knowledge about Abortion in Wake of Leaked Supreme Court Opinion
- The Availability and Use of Medication Abortion
- State Actions to Protect and Expand Access to Abortion Services
- Abortion at SCOTUS: Dobbs v. Jackson Women’s Health
- Employer Coverage of Travel Costs for Out-of-State Abortion
- ‘In Focus with KFF’: What Happens if Roe v. Wade is Overturned?
- The Intersection of State and Federal Policies on Access to Medication Abortion Via Telehealth
- Infographic: The Availability and Use of Medication Abortion Care
- Intersection of State Abortion Policy and Clinical Practice: June 2021 Update
- Medication Abortion and Telemedicine: Innovations and Barriers During the COVID-19 Emergency
- State Action to Limit Abortion Access During the COVID-19 Pandemic
- Interactive: How State Policies Shape Access to Abortion Coverage
- Abortion in the U.S. Dashboard
This Policy Watch takes a look at employers ability to access abortion information when their health plan covers abortion services. With some states criminalizing entities who assist in abortions, employers and providers face legal jeopardy and existing privacy laws such as HIPAA (the Health Insurance Portability and Accountability Act) may be limited in their privacy protections.
Blog See More
- view as grid
- view as list
With the country waiting on the Supreme Court’s decision on Dobbs v. Jackson Women’s Health Organization, the case that could overturn Roe v. Wade, many are looking towards telehealth as an alternative to expand access to medication abortion. A new KFF issue brief explains the newly revised Food and Drug…
This brief outlines the intersection of federal policy regarding dispensing medication abortion with state laws regulating the provision of abortion services and mifepristone dispensing via telehealth and considers the implications of the recent FDA change in different states.
This brief examines abortion laws in countries that received certain U.S. foreign assistance to better understand the implications of the Helms Amendment (which prohibits the use of foreign assistance to pay for the performance of abortion as a method of family planning or to motivate or coerce any person to practice abortion) for abortion access globally.
In this video, KFF Associate Director for Women’s Health Policy Laurie Sobel describes how a ruling overturning Roe could affect abortion access in the United States.
The Supreme Court, Congress, and state policymakers are currently debating issues that are central to women’s health and well-being. Watch the KFF Women’s Health Policy team web briefing to learn more about the status and implications of these debates, from abortion to paid leave.
On December 1, the Supreme Court will hear their first abortion case that could overturn Roe v. Wade, with a solid conservative majority. The case, Thomas E. Dobbs, State Health Officer of the Mississippi Department of Health v. Jackson Women’s Health Organization, involves a Mississippi law banning nearly all abortions…
Explore the latest national and state-specific data and policies on women’s health. Topics include health status, insurance and Medicaid coverage, use of preventive services, sexual health, maternal and infant health, and abortion policies. Many indicators provide state-level information for women of different racial and ethnic groups.
This infographic highlights data and policies regarding the availability and effectiveness of medication abortion in the United States. Medication abortion accounts for more than half (54%) of all abortions before nine weeks gestation in the U.S.
This interactive map shows the increase in states with laws restricting abortion coverage in Medicaid and private insurance since 2010.